tirzepatide approval canada FDA Grants a New Indication for Obesity Management Tirzepatide — 10 mg -

With these drugs, there are physiological changes in peoples bodies that change their desire for food, said Jonathan Bonnet, MD, a lifestyle medicine specialist at Stanford Medicine

Its a dual GLP-1 receptor agonist and glucose-dependent insulinotropic polypeptide (GIP)

doi: 10.1001/jamanetworkopen.2023.14493 142 WhartonSBlevinsTConneryLRosenstockJRahaSLiuRet al

Now, before we go any further, we dont have this long-term data yet for people with diabetes

Understanding these differences can help readers make better choices about which treatment may be safe and effective

These medicines work through well-defined biological mechanisms and are used as part of a medical treatment plan for overweight or obesity